Inhaled Ivermectin-Loaded Lipid Polymer Hybrid Nanoparticles: Development and Characterization
Seyedeh Negin Kassaee, Godwin A Ayoko, Derek Richard, Tony Wang, Nazrul Islam
Pharmaceutics, doi:10.3390/pharmaceutics16081061
Ivermectin (IVM), a drug originally used for treating parasitic infections, is being explored for its potential applications in cancer therapy. Despite the promising anti-cancer effects of IVM, its low water solubility limits its bioavailability and, consequently, its biological efficacy as an oral formulation. To overcome this challenge, our research focused on developing IVM-loaded lipid polymer hybrid nanoparticles (LPHNPs) designed for potential pulmonary administration. IVM-loaded LPHNPs were developed using the emulsion solvent evaporation method and characterized in terms of particle size, morphology, entrapment efficiency, and release pattern. Solid phase characterization was investigated by Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA). Using a Twin stage impinger (TSI) attached to a device, aerosolization properties of the developed LPHNPs were studied at a flow rate of 60 L/min, and IVM was determined by a validated HPLC method. IVM-loaded LPHNPs demonstrated spherical-shaped particles between 302 and 350 nm. Developed formulations showed an entrapment efficiency between 68 and 80% and a sustained 50 to 60% IVM release pattern within 96 h. Carr's index (CI), Hausner ratio (HR), and angle of repose (θ) indicated proper flowability of the fabricated LPHNPs. The in vitro aerosolization analysis revealed fine particle fractions (FPFs) ranging from 18.53% to 24.77%. This in vitro study demonstrates the potential of IVM-loaded LPHNPs as a delivery vehicle through the pulmonary route.
Conflicts of Interest: The authors have declared no conflicts of interest.
References
Abdelaziz, Gaber, Abd-Elwakil, Mabrouk, Elgohary et al., Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates, J. Control. Release,
doi:10.1016/j.jconrel.2017.11.036Abou-Elnour, El-Habashy, Essawy, Abdallah, Codelivery of ivermectin and methyl dihydrojasmonate in nanostructured lipid carrier for synergistic antileukemia therapy, Int. J. Pharm,
doi:10.1016/j.ijpharm.2024.124086Ali, Afzal, Verma, Misra-Bhattacharya, Ahmad et al., Improved antifilarial activity of ivermectin in chitosan-alginate nanoparticles against human lymphatic filarial parasite, Brugia malayi, Parasitol. Res,
doi:10.1007/s00436-013-3466-4Anderson, Grimmett, Domalewski, Cui, Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol,
doi:10.1002/wnan.1586Bardoliwala, Patel, Misra, Sawant, Systematic development and characterization of inhalable dry powder containing Polymeric Lipid Hybrid Nanocarriers co-loaded with ABCB1 shRNA and docetaxel using QbD approach, J. Drug Deliv. Sci. Technol,
doi:10.1016/j.jddst.2021.102903Bhardwaj, Mehta, Yadav, Singh, Grobler et al., Pulmonary delivery of antitubercular drugs using spray-dried lipid-polymer hybrid nanoparticles, Artif. Cells Nanomed. Biotechnol,
doi:10.3109/21691401.2015.1062389Conte, Costabile, Baldassi, Rondelli, Bassi et al., Hybrid lipid/polymer nanoparticles to tackle the cystic fibrosis mucus barrier in siRNA delivery to the lungs: Does PEGylation make the difference?, ACS Appl. Mater. Interfaces,
doi:10.1021/acsami.1c14975Craparo, Cabibbo, Scialabba, Giammona, Cavallaro, Inhalable Formulation Based on Lipid-Polymer Hybrid Nanoparticles for the Macrophage Targeted Delivery of Roflumilast, Biomacromolecules,
doi:10.1021/acs.biomac.2c00576Das, Lee, Chia, Chow, Macbeath et al., Development of microemulsion based topical ivermectin formulations: Pre-formulation and formulation studies, Colloids Surf. B Biointerfaces,
doi:10.1016/j.colsurfb.2020.110823Dave, Tak, Sohgaura, Gupta, Sadhu et al., Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical applications, J. Microbiol. Methods,
doi:10.1016/j.mimet.2019.03.017De Souza, Júnior, Pinheiro, De Souza Rebouças, De Abreu et al., Ameliorating the antiparasitic activity of the multifaceted drug ivermectin through a polymer nanocapsule formulation, Int. J. Pharm,
doi:10.1016/j.ijpharm.2023.122965Dong, Zhuang, Insights into Inhalation Drug Disposition: The Roles of Pulmonary Drug-Metabolizing Enzymes and Transporters, Int. J. Mol. Sci,
doi:10.3390/ijms25094671Doroudian, O'neill, Mac Loughlin, Prina-Mello, Volkov et al., Nanotechnology in pulmonary medicine, Curr. Opin. Pharmacol,
doi:10.1016/j.coph.2020.11.002Esfahani, Islam, Cabot, Izake, Development of thiabendazole-loaded mesoporous silica nanoparticles for cancer therapy, ACS Biomater. Sci. Eng,
doi:10.1021/acsbiomaterials.1c00066Ferreira, Chaves, Lima, Reis, Optimization of nanostructured lipid carriers loaded with methotrexate: A tool for inflammatory and cancer therapy, Int. J. Pharm,
doi:10.1016/j.ijpharm.2015.07.013Gajbhiye, Salve, Narwade, Sheikh, Kesharwani et al., Lipid polymer hybrid nanoparticles: A custom-tailored next-generation approach for cancer therapeutics, Mol. Cancer,
doi:10.1186/s12943-023-01849-0Gajra, Dalwadi, Patel, Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using box behnken design, DARU J. Pharm. Sci,
doi:10.1186/s40199-014-0087-0Gan, Dai, Yuan, Qian, Sha et al., Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery, Biomed. Microdevices,
doi:10.1007/s10544-011-9604-9Godara, Lather, Kirthanashri, Awasthi, Pandita, Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation, Mater. Sci. Eng. C,
doi:10.1016/j.msec.2019.110576Guo, Dou, Li, Zhang, Bhutto et al., Ivermection-loaded solid lipid nanoparticles: Preparation, characterisation, stability and transdermal behaviour, Artif. Cells Nanomed. Biotechnol,
doi:10.1080/21691401.2017.1307207Hadinoto, Sundaresan, Cheow, Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review, Eur. J. Pharm. Biopharm,
doi:10.1016/j.ejpb.2013.07.002Honary, Zahir, Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 2), Trop. J. Pharm. Res
Hu, Dong, Pastorin, Ng, Tan, Spherical agglomerates of pure drug nanoparticles for improved pulmonary delivery in dry powder inhalers, J. Nanopart. Res,
doi:10.1007/s11051-013-1560-2Islam, Rahman, Pulmonary drug delivery: Implication for new strategy for pharmacotherapy for neurodegenerative disorders, Drug Discov. Ther
Jahromi, Ghazali, Ashrafi, Azadi, A comparison of models for the analysis of the kinetics of drug release from PLGA-based nanoparticles, Heliyon,
doi:10.1016/j.heliyon.2020.e03451Kassaee, Nili-Ahmadabadi, Mahboobian, Fabrication of poloxamer based besifloxacin thermosensitive in situ gelling nanoemulsions for ophthalmic delivery, J. Bioact. Compat. Polym,
doi:10.1177/08839115231167587Khan, Aamir, Madni, Jan, Khan et al., Lipid poly (E-caprolactone) hybrid nanoparticles of 5-fluorouracil for sustained release and enhanced anticancer efficacy, Life Sci,
doi:10.1016/j.lfs.2021.119909Kovacevic, Savic, Vuleta, Mueller, Keck, Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): Effects on size, physical stability and particle matrix structure, Int. J. Pharm,
doi:10.1016/j.ijpharm.2010.12.036Kumbhar, Manjappa, Shah, Jha, Singh et al., Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges, J. Control. Release,
doi:10.1016/j.jconrel.2021.11.015Kuperkar, Atanase, Bahadur, Crivei, Bahadur, Degradable polymeric bio (nano) materials and their biomedical applications: A comprehensive overview and recent updates, Polymers,
doi:10.3390/polym16020206Li, Wong, Shuhendler, Rauth, Wu, Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles, J. Control. Release,
doi:10.1016/j.jconrel.2008.02.014Liu, Cheng, Xin, Liu, Wang et al., Nanoparticles advanced from preclinical studies to clinical trials for lung cancer therapy, Cancer Nanotechnol,
doi:10.1186/s12645-023-00174-xLiu, Pan, Feng, Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: Effects of surfactants on particles size, characteristics and in vitro performance, Int. J. Pharm,
doi:10.1016/j.ijpharm.2010.05.008Liu, Zhao, Zhu, Cheng, Liu et al., Docetaxel liposomes for lung targeted delivery: Development and evaluation, Pharm. Dev. Technol,
doi:10.1080/10837450.2023.2265472Lu, Xiong, Sun, Yu, Hu et al., Sustained release ivermectin-loaded solid lipid dispersion for subcutaneous delivery: In vitro and in vivo evaluation, Drug Deliv,
doi:10.1080/10717544.2017.1284945Macho, Demková, Gabrišová, Čierny, Mužíková et al., Analysis of static angle of repose with respect to powder material properties, Acta Polytech,
doi:10.14311/AP.2020.60.0073Majeed, Manochakian, Zhao, Lou, Targeted therapy in advanced non-small cell lung cancer: Current advances and future trends, J. Hematol. Oncol,
doi:10.1186/s13045-021-01121-2Mandal, Mittal, Balabathula, Thoma, Wood, Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer, Eur. J. Pharm. Sci,
doi:10.1016/j.ejps.2015.10.021Marante, Viegas, Duarte, Macedo, Fonte, An overview on spray-drying of protein-loaded polymeric nanoparticles for dry powder inhalation, Pharmaceutics,
doi:10.3390/pharmaceutics12111032Mohammed, El-Megrab, Hasan, Gomaa, A remodeled ivermectin polycaprolactone-based nanoparticles for inhalation as a promising treatment of pulmonary inflammatory diseases, Eur. J. Pharm. Sci,
doi:10.1016/j.ejps.2024.106714Mukherjee, Waters, Kalyan, Achrol, Kesari et al., Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: State of the art, emerging technologies, and perspectives, Int. J. Nanomed,
doi:10.2147/IJN.S198353Noori, Dehpour, Alavi, Hosseini, Korani et al., Synthesis and evaluation of the effects of solid lipid nanoparticles of ivermectin and ivermectin on cuprizone-induced demyelination via targeting the TRPA1/NF-kB/GFAP signaling pathway, J. Basic Med. Sci
Othman, Vladisavljevic, Nagy, Holdich, Encapsulation and controlled release of rapamycin from polycaprolactone nanoparticles prepared by membrane micromixing combined with antisolvent precipitation, Langmuir,
doi:10.1021/acs.langmuir.6b03178Patel, Bardoliwala, Lalani, Patil, Ghosh et al., Development of a dry powder for inhalation of nanoparticles codelivering cisplatin and ABCC3 siRNA in lung cancer, Ther. Deliv,
doi:10.4155/tde-2020-0117Patel, Karampuri, Kansara, Vyas, Inhalable dry powder containing lipid polymer hybrid nanoparticles of Nintedanib esylate: In vitro and in vivo evaluations, J. Drug Deliv. Sci. Technol,
doi:10.1016/j.jddst.2023.104716Pellosi, Angelo, Maiolino, Mitidieri, Di Villa Bianca et al., In vitro/in vivo investigation on the potential of Pluronic ® mixed micelles for pulmonary drug delivery, Eur. J. Pharm. Biopharm,
doi:10.1016/j.ejpb.2018.06.006Ren, Qi, Ruan, Cao, Ma et al., Selenized polymer-lipid hybrid nanoparticles for oral delivery of tripterine with ameliorative oral anti-enteritis activity and bioavailability, Pharmaceutics,
doi:10.3390/pharmaceutics15030821Sabuj, Dargaville, Nissen, Islam, Inhaled ciprofloxacin-loaded poly (2-ethyl-2-oxazoline) nanoparticles from dry powder inhaler formulation for the potential treatment of lower respiratory tract infections, PLoS ONE,
doi:10.1371/journal.pone.0261720Sengel-Turk, Hascicek, Design of lipid-polymer hybrid nanoparticles for therapy of BPH: Part I. Formulation optimization using a design of experiment approach, J. Drug Deliv. Sci. Technol,
doi:10.1016/j.jddst.2017.02.012Shen, Wu, Liu, Wu, High drug-loading nanomedicines: Progress, current status, and prospects, Int. J. Nanomed,
doi:10.2147/IJN.S132780Sinha, Mukherjee, Development of an inhalation chamber and a dry powder inhaler device for administration of pulmonary medication in animal model, Drug Dev. Ind. Pharm,
doi:10.3109/03639045.2011.592532Soomherun, Kreua-Ongarjnukool, Niyomthai, Chumnanvej, Lipid-Polymer Hybrid Nanoparticles Synthesized via Lipid-Based Surface Engineering for a robust drug delivery platform, Colloids Surf. B Biointerfaces,
doi:10.1016/j.colsurfb.2024.113858Tahir, Madni, Balasubramanian, Rehman, Correia et al., Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications, Int. J. Pharm,
doi:10.1016/j.ijpharm.2017.09.061Tang, Hu, Wang, Yao, Zhang et al., Ivermectin, a potential anticancer drug derived from an antiparasitic drug, Pharmacol. Res,
doi:10.1016/j.phrs.2020.105207Tang, Zhang, Sun, Luo, Zhou et al., Pulmonary delivery of mucus-traversing PF127-modified silk fibroin nanoparticles loading with quercetin for lung cancer therapy, Asian J. Pharm. Sci,
doi:10.1016/j.ajps.2023.100833Thakur, Chellappan, Dua, Mehta, Satija et al., Patented therapeutic drug delivery strategies for targeting pulmonary diseases, Expert Opin. Ther. Pat,
doi:10.1080/13543776.2020.1741547Thanki, Van Eetvelde, Geyer, Fraire, Hendrix et al., Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration, J. Control. Release,
doi:10.1016/j.jconrel.2019.08.004Tiyaboonchai, Tungpradit, Plianbangchang, Formulation and characterization of curcuminoids loaded solid lipid nanoparticles, Int. J. Pharm,
doi:10.1016/j.ijpharm.2006.12.043Valarini Junior, Cardoso, De Souza, Machado Giufrida, Cardozo-Filho, Single step encapsulation process of ivermectin in biocompatible polymer using a supercritical antisolvent system process, Asia-Pac. J. Chem. Eng,
doi:10.1002/apj.2672Velho, Funk, Deon, Benvenutti, Buchner et al., Ivermectin-Loaded Mesoporous Silica and Polymeric Nanocapsules: Impact on Drug Loading, In Vitro Solubility Enhancement, and Release Performance, Pharmaceutics,
doi:10.3390/pharmaceutics16030325Vencken, Foged, Ramsey, Sweeney, Cryan et al., Nebulised lipid-polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells, ERJ Open Res,
doi:10.1183/23120541.00161-2018Wadhwa, Bobak, Bohrmann, Geczy, Sekar et al., Pulmonary delivery of siRNA-loaded lipid-polymer hybrid nanoparticles: Effect of nanoparticle size, OpenNano,
doi:10.1016/j.onano.2023.100180Wang, George, Bartlett, Gao, Islam, Nicotine hydrogen tartrate loaded chitosan nanoparticles: Formulation, characterization and in vitro delivery from dry powder inhaler formulation, Eur. J. Pharm. Biopharm,
doi:10.1016/j.ejpb.2016.12.023Wang, Holgate, Bartlett, Islam, Assessment of nicotine release from nicotine-loaded chitosan nanoparticles dry powder inhaler formulations via locomotor activity of C57BL/6 mice, Eur. J. Pharm. Biopharm
{ 'indexed': {'date-parts': [[2024, 8, 14]], 'date-time': '2024-08-14T00:27:14Z', 'timestamp': 1723595234897},
'reference-count': 70,
'publisher': 'MDPI AG',
'issue': '8',
'license': [ { 'start': { 'date-parts': [[2024, 8, 12]],
'date-time': '2024-08-12T00:00:00Z',
'timestamp': 1723420800000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by/4.0/'}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'abstract': '<jats:p>Ivermectin (IVM), a drug originally used for treating parasitic infections, is being '
'explored for its potential applications in cancer therapy. Despite the promising anti-cancer '
'effects of IVM, its low water solubility limits its bioavailability and, consequently, its '
'biological efficacy as an oral formulation. To overcome this challenge, our research focused '
'on developing IVM-loaded lipid polymer hybrid nanoparticles (LPHNPs) designed for potential '
'pulmonary administration. IVM-loaded LPHNPs were developed using the emulsion solvent '
'evaporation method and characterized in terms of particle size, morphology, entrapment '
'efficiency, and release pattern. Solid phase characterization was investigated by Fourier '
'transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and '
'thermogravimetric analysis (TGA). Using a Twin stage impinger (TSI) attached to a device, '
'aerosolization properties of the developed LPHNPs were studied at a flow rate of 60 L/min, '
'and IVM was determined by a validated HPLC method. IVM-loaded LPHNPs demonstrated '
'spherical-shaped particles between 302 and 350 nm. Developed formulations showed an '
'entrapment efficiency between 68 and 80% and a sustained 50 to 60% IVM release pattern within '
'96 h. Carr’s index (CI), Hausner ratio (HR), and angle of repose (θ) indicated proper '
'flowability of the fabricated LPHNPs. The in vitro aerosolization analysis revealed fine '
'particle fractions (FPFs) ranging from 18.53% to 24.77%. This in vitro study demonstrates the '
'potential of IVM-loaded LPHNPs as a delivery vehicle through the pulmonary route.</jats:p>',
'DOI': '10.3390/pharmaceutics16081061',
'type': 'journal-article',
'created': {'date-parts': [[2024, 8, 13]], 'date-time': '2024-08-13T10:02:37Z', 'timestamp': 1723543357000},
'page': '1061',
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'Inhaled Ivermectin-Loaded Lipid Polymer Hybrid Nanoparticles: Development and Characterization',
'prefix': '10.3390',
'volume': '16',
'author': [ { 'ORCID': 'http://orcid.org/0000-0002-4000-3498',
'authenticated-orcid': False,
'given': 'Seyedeh Negin',
'family': 'Kassaee',
'sequence': 'first',
'affiliation': [ { 'name': 'Pharmacy Discipline, School of Clinical Sciences, Faculty of '
'Health, Queensland University of Technology (QUT), Brisbane, QLD '
'4000, Australia'}]},
{ 'given': 'Godwin A.',
'family': 'Ayoko',
'sequence': 'additional',
'affiliation': [ { 'name': 'School of Chemistry and Physics, Science and Engineering '
'Faculty, Queensland University of Technology (QUT), Brisbane, '
'QLD 4000, Australia'}]},
{ 'given': 'Derek',
'family': 'Richard',
'sequence': 'additional',
'affiliation': [ { 'name': 'Centre for Genomics and Personalised Health, School of '
'Biomedical Sciences, Queensland University of Technology (QUT), '
'Brisbane, QLD 4000, Australia'}]},
{ 'ORCID': 'http://orcid.org/0000-0003-4278-0888',
'authenticated-orcid': False,
'given': 'Tony',
'family': 'Wang',
'sequence': 'additional',
'affiliation': [ { 'name': 'Central Analytical Research Facility, Institution for Future '
'Environment, Queensland University of Technology (QUT), '
'Brisbane, QLD 4000, Australia'}]},
{ 'ORCID': 'http://orcid.org/0000-0001-6751-6915',
'authenticated-orcid': False,
'given': 'Nazrul',
'family': 'Islam',
'sequence': 'additional',
'affiliation': [ { 'name': 'Pharmacy Discipline, School of Clinical Sciences, Faculty of '
'Health, Queensland University of Technology (QUT), Brisbane, QLD '
'4000, Australia'},
{ 'name': 'Centre for Materials Science, Queensland University of '
'Technology, Brisbane, QLD 4000, Australia'},
{ 'name': 'Centre for Immunology and Infection Control (CIIC), Queensland '
'University of Technology (QUT), Brisbane, QLD 4000, '
'Australia'}]}],
'member': '1968',
'published-online': {'date-parts': [[2024, 8, 12]]},
'reference': [ { 'key': 'ref_1',
'doi-asserted-by': 'crossref',
'first-page': '375',
'DOI': '10.1080/13543776.2020.1741547',
'article-title': 'Patented therapeutic drug delivery strategies for targeting pulmonary '
'diseases',
'volume': '30',
'author': 'Thakur',
'year': '2020',
'journal-title': 'Expert Opin. Ther. Pat.'},
{ 'key': 'ref_2',
'first-page': '264',
'article-title': 'Pulmonary drug delivery: Implication for new strategy for '
'pharmacotherapy for neurodegenerative disorders',
'volume': '2',
'author': 'Islam',
'year': '2008',
'journal-title': 'Drug Discov. Ther.'},
{ 'key': 'ref_3',
'doi-asserted-by': 'crossref',
'unstructured': 'Dong, L., and Zhuang, X. (2024). Insights into Inhalation Drug '
'Disposition: The Roles of Pulmonary Drug-Metabolizing Enzymes and '
'Transporters. Int. J. Mol. Sci., 25.',
'DOI': '10.3390/ijms25094671'},
{ 'key': 'ref_4',
'doi-asserted-by': 'crossref',
'unstructured': 'Gandhi, S., and Roy, I. (2023). Lipid-Based inhalable micro-and '
'nanocarriers of active agents for treating non-small-cell lung cancer. '
'Pharmaceutics, 15.',
'DOI': '10.3390/pharmaceutics15051457'},
{ 'key': 'ref_5',
'doi-asserted-by': 'crossref',
'first-page': '85',
'DOI': '10.1016/j.coph.2020.11.002',
'article-title': 'Nanotechnology in pulmonary medicine',
'volume': '56',
'author': 'Doroudian',
'year': '2021',
'journal-title': 'Curr. Opin. Pharmacol.'},
{ 'key': 'ref_6',
'doi-asserted-by': 'crossref',
'first-page': '28',
'DOI': '10.1186/s12645-023-00174-x',
'article-title': 'Nanoparticles advanced from preclinical studies to clinical trials for '
'lung cancer therapy',
'volume': '14',
'author': 'Liu',
'year': '2023',
'journal-title': 'Cancer Nanotechnol.'},
{ 'key': 'ref_7',
'doi-asserted-by': 'crossref',
'first-page': '1563',
'DOI': '10.1158/1055-9965.EPI-19-0221',
'article-title': 'Cancer progress and priorities: Lung cancer',
'volume': '28',
'author': 'Schabath',
'year': '2019',
'journal-title': 'Cancer Epidemiol. Biomark. Prev.'},
{ 'key': 'ref_8',
'doi-asserted-by': 'crossref',
'first-page': '108',
'DOI': '10.1186/s13045-021-01121-2',
'article-title': 'Targeted therapy in advanced non-small cell lung cancer: Current '
'advances and future trends',
'volume': '14',
'author': 'Majeed',
'year': '2021',
'journal-title': 'J. Hematol. Oncol.'},
{ 'key': 'ref_9',
'doi-asserted-by': 'crossref',
'first-page': '162',
'DOI': '10.1016/j.ejps.2015.10.021',
'article-title': 'Development and in vitro evaluation of core–shell type lipid–polymer '
'hybrid nanoparticles for the delivery of erlotinib in non-small cell '
'lung cancer',
'volume': '81',
'author': 'Mandal',
'year': '2016',
'journal-title': 'Eur. J. Pharm. Sci.'},
{ 'key': 'ref_10',
'doi-asserted-by': 'crossref',
'first-page': '1',
'DOI': '10.1016/j.jconrel.2021.11.015',
'article-title': 'Inhalation delivery of repurposed drugs for lung cancer: Approaches, '
'benefits and challenges',
'volume': '341',
'author': 'Kumbhar',
'year': '2022',
'journal-title': 'J. Control. Release'},
{ 'key': 'ref_11',
'doi-asserted-by': 'crossref',
'first-page': '106714',
'DOI': '10.1016/j.ejps.2024.106714',
'article-title': 'A remodeled ivermectin polycaprolactone-based nanoparticles for '
'inhalation as a promising treatment of pulmonary inflammatory diseases',
'volume': '195',
'author': 'Mohammed',
'year': '2024',
'journal-title': 'Eur. J. Pharm. Sci.'},
{ 'key': 'ref_12',
'doi-asserted-by': 'crossref',
'first-page': '105207',
'DOI': '10.1016/j.phrs.2020.105207',
'article-title': 'Ivermectin, a potential anticancer drug derived from an antiparasitic '
'drug',
'volume': '163',
'author': 'Tang',
'year': '2021',
'journal-title': 'Pharmacol. Res.'},
{ 'key': 'ref_13',
'doi-asserted-by': 'crossref',
'first-page': '571',
'DOI': '10.1080/15563650.2022.2043338',
'article-title': 'Ivermectin: A mini-review',
'volume': '60',
'year': '2022',
'journal-title': 'Clin. Toxicol.'},
{ 'key': 'ref_14',
'doi-asserted-by': 'crossref',
'first-page': '122965',
'DOI': '10.1016/j.ijpharm.2023.122965',
'article-title': 'Ameliorating the antiparasitic activity of the multifaceted drug '
'ivermectin through a polymer nanocapsule formulation',
'volume': '639',
'author': 'Pinheiro',
'year': '2023',
'journal-title': 'Int. J. Pharm.'},
{ 'key': 'ref_15',
'doi-asserted-by': 'crossref',
'first-page': '4153',
'DOI': '10.1021/acsbiomaterials.1c00066',
'article-title': 'Development of thiabendazole-loaded mesoporous silica nanoparticles for '
'cancer therapy',
'volume': '8',
'author': 'Esfahani',
'year': '2021',
'journal-title': 'ACS Biomater. Sci. Eng.'},
{ 'key': 'ref_16',
'doi-asserted-by': 'crossref',
'first-page': '374',
'DOI': '10.1016/j.jconrel.2017.11.036',
'article-title': 'Inhalable particulate drug delivery systems for lung cancer therapy: '
'Nanoparticles, microparticles, nanocomposites and nanoaggregates',
'volume': '269',
'author': 'Abdelaziz',
'year': '2018',
'journal-title': 'J. Control. Release'},
{ 'key': 'ref_17',
'doi-asserted-by': 'crossref',
'first-page': '1937',
'DOI': '10.2147/IJN.S198353',
'article-title': 'Lipid–polymer hybrid nanoparticles as a next-generation drug delivery '
'platform: State of the art, emerging technologies, and perspectives',
'volume': '14',
'author': 'Mukherjee',
'year': '2019',
'journal-title': 'Int. J. Nanomed.'},
{ 'key': 'ref_18',
'doi-asserted-by': 'crossref',
'unstructured': 'Kuperkar, K., Atanase, L.I., Bahadur, A., Crivei, I.C., and Bahadur, P. '
'(2024). Degradable polymeric bio (nano) materials and their biomedical '
'applications: A comprehensive overview and recent updates. Polymers, 16.',
'DOI': '10.3390/polym16020206'},
{ 'key': 'ref_19',
'doi-asserted-by': 'crossref',
'first-page': '160',
'DOI': '10.1186/s12943-023-01849-0',
'article-title': 'Lipid polymer hybrid nanoparticles: A custom-tailored next-generation '
'approach for cancer therapeutics',
'volume': '22',
'author': 'Gajbhiye',
'year': '2023',
'journal-title': 'Mol. Cancer'},
{ 'key': 'ref_20',
'doi-asserted-by': 'crossref',
'unstructured': 'Anderson, C.F., Grimmett, M.E., Domalewski, C.J., and Cui, H. (2020). '
'Inhalable nanotherapeutics to improve treatment efficacy for common lung '
'diseases. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 12.',
'DOI': '10.1002/wnan.1586'},
{ 'key': 'ref_21',
'doi-asserted-by': 'crossref',
'first-page': '427',
'DOI': '10.1016/j.ejpb.2013.07.002',
'article-title': 'Lipid–polymer hybrid nanoparticles as a new generation therapeutic '
'delivery platform: A review',
'volume': '85',
'author': 'Hadinoto',
'year': '2013',
'journal-title': 'Eur. J. Pharm. Biopharm.'},
{ 'key': 'ref_22',
'doi-asserted-by': 'crossref',
'first-page': '130',
'DOI': '10.1016/j.mimet.2019.03.017',
'article-title': 'Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical '
'applications',
'volume': '160',
'author': 'Dave',
'year': '2019',
'journal-title': 'J. Microbiol. Methods'},
{ 'key': 'ref_23',
'doi-asserted-by': 'crossref',
'first-page': '102903',
'DOI': '10.1016/j.jddst.2021.102903',
'article-title': 'Systematic development and characterization of inhalable dry powder '
'containing Polymeric Lipid Hybrid Nanocarriers co-loaded with ABCB1 '
'shRNA and docetaxel using QbD approach',
'volume': '66',
'author': 'Bardoliwala',
'year': '2021',
'journal-title': 'J. Drug Deliv. Sci. Technol.'},
{ 'key': 'ref_24',
'doi-asserted-by': 'crossref',
'first-page': '651',
'DOI': '10.4155/tde-2020-0117',
'article-title': 'Development of a dry powder for inhalation of nanoparticles '
'codelivering cisplatin and ABCC3 siRNA in lung cancer',
'volume': '12',
'author': 'Patel',
'year': '2021',
'journal-title': 'Ther. Deliv.'},
{ 'key': 'ref_25',
'doi-asserted-by': 'crossref',
'first-page': '1544',
'DOI': '10.3109/21691401.2015.1062389',
'article-title': 'Pulmonary delivery of antitubercular drugs using spray-dried '
'lipid–polymer hybrid nanoparticles',
'volume': '44',
'author': 'Bhardwaj',
'year': '2016',
'journal-title': 'Artif. Cells Nanomed. Biotechnol.'},
{ 'key': 'ref_26',
'doi-asserted-by': 'crossref',
'first-page': '82',
'DOI': '10.1016/j.jconrel.2019.08.004',
'article-title': 'Mechanistic profiling of the release kinetics of siRNA from '
'lipidoid-polymer hybrid nanoparticles in vitro and in vivo after '
'pulmonary administration',
'volume': '310',
'author': 'Thanki',
'year': '2019',
'journal-title': 'J. Control. Release'},
{ 'key': 'ref_27',
'doi-asserted-by': 'crossref',
'first-page': '161',
'DOI': '10.1183/23120541.00161-2018',
'article-title': 'Nebulised lipid–polymer hybrid nanoparticles for the delivery of a '
'therapeutic anti-inflammatory microRNA to bronchial epithelial cells',
'volume': '5',
'author': 'Vencken',
'year': '2019',
'journal-title': 'ERJ Open Res.'},
{ 'key': 'ref_28',
'doi-asserted-by': 'crossref',
'first-page': '7565',
'DOI': '10.1021/acsami.1c14975',
'article-title': 'Hybrid lipid/polymer nanoparticles to tackle the cystic fibrosis mucus '
'barrier in siRNA delivery to the lungs: Does PEGylation make the '
'difference?',
'volume': '14',
'author': 'Conte',
'year': '2022',
'journal-title': 'ACS Appl. Mater. Interfaces'},
{ 'key': 'ref_29',
'doi-asserted-by': 'crossref',
'first-page': '3439',
'DOI': '10.1021/acs.biomac.2c00576',
'article-title': 'Inhalable Formulation Based on Lipid–Polymer Hybrid Nanoparticles for '
'the Macrophage Targeted Delivery of Roflumilast',
'volume': '23',
'author': 'Craparo',
'year': '2022',
'journal-title': 'Biomacromolecules'},
{ 'key': 'ref_30',
'doi-asserted-by': 'crossref',
'first-page': '104716',
'DOI': '10.1016/j.jddst.2023.104716',
'article-title': 'Inhalable dry powder containing lipid polymer hybrid nanoparticles of '
'Nintedanib esylate: In vitro and in vivo evaluations',
'volume': '86',
'author': 'Patel',
'year': '2023',
'journal-title': 'J. Drug Deliv. Sci. Technol.'},
{ 'key': 'ref_31',
'doi-asserted-by': 'crossref',
'first-page': '100180',
'DOI': '10.1016/j.onano.2023.100180',
'article-title': 'Pulmonary delivery of siRNA-loaded lipid-polymer hybrid nanoparticles: '
'Effect of nanoparticle size',
'volume': '13',
'author': 'Wadhwa',
'year': '2023',
'journal-title': 'OpenNano'},
{ 'key': 'ref_32',
'doi-asserted-by': 'crossref',
'first-page': '100833',
'DOI': '10.1016/j.ajps.2023.100833',
'article-title': 'Pulmonary delivery of mucus-traversing PF127-modified silk fibroin '
'nanoparticles loading with quercetin for lung cancer therapy',
'volume': '18',
'author': 'Tang',
'year': '2023',
'journal-title': 'Asian J. Pharm. Sci.'},
{ 'key': 'ref_33',
'doi-asserted-by': 'crossref',
'first-page': '30',
'DOI': '10.1016/j.ejpb.2018.06.006',
'article-title': 'In vitro/in vivo investigation on the potential of Pluronic® mixed '
'micelles for pulmonary drug delivery',
'volume': '130',
'author': 'Pellosi',
'year': '2018',
'journal-title': 'Eur. J. Pharm. Biopharm.'},
{ 'key': 'ref_34',
'doi-asserted-by': 'crossref',
'first-page': '110576',
'DOI': '10.1016/j.msec.2019.110576',
'article-title': 'Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, '
'characterization, in vitro and in vivo evaluation',
'volume': '109',
'author': 'Godara',
'year': '2020',
'journal-title': 'Mater. Sci. Eng. C'},
{ 'key': 'ref_35',
'doi-asserted-by': 'crossref',
'first-page': '255',
'DOI': '10.1080/21691401.2017.1307207',
'article-title': 'Ivermection-loaded solid lipid nanoparticles: Preparation, '
'characterisation, stability and transdermal behaviour',
'volume': '46',
'author': 'Guo',
'year': '2018',
'journal-title': 'Artif. Cells Nanomed. Biotechnol.'},
{ 'key': 'ref_36',
'doi-asserted-by': 'crossref',
'first-page': '118',
'DOI': '10.1016/j.ejpb.2016.12.023',
'article-title': 'Nicotine hydrogen tartrate loaded chitosan nanoparticles: Formulation, '
'characterization and in vitro delivery from dry powder inhaler '
'formulation',
'volume': '113',
'author': 'Wang',
'year': '2017',
'journal-title': 'Eur. J. Pharm. Biopharm.'},
{ 'key': 'ref_37',
'doi-asserted-by': 'crossref',
'unstructured': 'Das, S., Lee, S.H., Chia, V.D., Chow, P.S., Macbeath, C., Liu, Y., and '
'Shlieout, G. (2020). Development of microemulsion based topical '
'ivermectin formulations: Pre-formulation and formulation studies. '
'Colloids Surf. B Biointerfaces, 189.',
'DOI': '10.1016/j.colsurfb.2020.110823'},
{ 'key': 'ref_38',
'doi-asserted-by': 'crossref',
'first-page': '742',
'DOI': '10.1093/chromsci/bmx030',
'article-title': 'LC–MS/MS determination of empagliflozin and metformin',
'volume': '55',
'author': 'Ayoub',
'year': '2017',
'journal-title': 'J. Chromatogr. Sci.'},
{ 'key': 'ref_39',
'doi-asserted-by': 'crossref',
'unstructured': 'Ren, Y., Qi, C., Ruan, S., Cao, G., Ma, Z., and Zhang, X. (2023). '
'Selenized polymer-lipid hybrid nanoparticles for oral delivery of '
'tripterine with ameliorative oral anti-enteritis activity and '
'bioavailability. Pharmaceutics, 15.',
'DOI': '10.3390/pharmaceutics15030821'},
{ 'key': 'ref_40',
'doi-asserted-by': 'crossref',
'first-page': '3',
'DOI': '10.1186/s40199-014-0087-0',
'article-title': 'Formulation and optimization of itraconazole polymeric lipid hybrid '
'nanoparticles (Lipomer) using box behnken design',
'volume': '23',
'author': 'Gajra',
'year': '2015',
'journal-title': 'DARU J. Pharm. Sci.'},
{ 'key': 'ref_41',
'doi-asserted-by': 'crossref',
'first-page': '119909',
'DOI': '10.1016/j.lfs.2021.119909',
'article-title': 'Lipid poly (ɛ-caprolactone) hybrid nanoparticles of 5-fluorouracil for '
'sustained release and enhanced anticancer efficacy',
'volume': '284',
'author': 'Khan',
'year': '2021',
'journal-title': 'Life Sci.'},
{ 'key': 'ref_42',
'doi-asserted-by': 'crossref',
'first-page': '299',
'DOI': '10.1016/j.ijpharm.2006.12.043',
'article-title': 'Formulation and characterization of curcuminoids loaded solid lipid '
'nanoparticles',
'volume': '337',
'author': 'Tiyaboonchai',
'year': '2007',
'journal-title': 'Int. J. Pharm.'},
{ 'key': 'ref_43',
'doi-asserted-by': 'crossref',
'unstructured': 'Sabuj, M.Z.R., Dargaville, T.R., Nissen, L., and Islam, N. (2021). '
'Inhaled ciprofloxacin-loaded poly (2-ethyl-2-oxazoline) nanoparticles '
'from dry powder inhaler formulation for the potential treatment of lower '
'respiratory tract infections. PLoS ONE, 16.',
'DOI': '10.1371/journal.pone.0261720'},
{ 'key': 'ref_44',
'doi-asserted-by': 'crossref',
'first-page': '163',
'DOI': '10.1016/j.ijpharm.2010.12.036',
'article-title': 'Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN '
'and NLC): Effects on size, physical stability and particle matrix '
'structure',
'volume': '406',
'author': 'Kovacevic',
'year': '2011',
'journal-title': 'Int. J. Pharm.'},
{ 'key': 'ref_45',
'first-page': '265',
'article-title': 'Effect of zeta potential on the properties of nano-drug delivery '
'systems-a review (Part 2)',
'volume': '12',
'author': 'Honary',
'year': '2013',
'journal-title': 'Trop. J. Pharm. Res.'},
{ 'key': 'ref_46',
'doi-asserted-by': 'crossref',
'first-page': '243',
'DOI': '10.1016/j.ijpharm.2010.05.008',
'article-title': 'Nanoparticles of lipid monolayer shell and biodegradable polymer core '
'for controlled release of paclitaxel: Effects of surfactants on '
'particles size, characteristics and in vitro performance',
'volume': '395',
'author': 'Liu',
'year': '2010',
'journal-title': 'Int. J. Pharm.'},
{ 'key': 'ref_47',
'doi-asserted-by': 'crossref',
'first-page': '156',
'DOI': '10.1016/j.ijpharm.2017.09.061',
'article-title': 'Development and optimization of methotrexate-loaded lipid-polymer '
'hybrid nanoparticles for controlled drug delivery applications',
'volume': '533',
'author': 'Tahir',
'year': '2017',
'journal-title': 'Int. J. Pharm.'},
{ 'key': 'ref_48',
'doi-asserted-by': 'crossref',
'first-page': '65',
'DOI': '10.1016/j.ijpharm.2015.07.013',
'article-title': 'Optimization of nanostructured lipid carriers loaded with methotrexate: '
'A tool for inflammatory and cancer therapy',
'volume': '492',
'author': 'Ferreira',
'year': '2015',
'journal-title': 'Int. J. Pharm.'},
{ 'key': 'ref_49',
'doi-asserted-by': 'crossref',
'first-page': '2143',
'DOI': '10.1002/cplu.202000496',
'article-title': 'Development of high-drug-loading nanoparticles',
'volume': '85',
'author': 'Liu',
'year': '2020',
'journal-title': 'ChemPlusChem'},
{ 'key': 'ref_50',
'doi-asserted-by': 'crossref',
'first-page': '4085',
'DOI': '10.2147/IJN.S132780',
'article-title': 'High drug-loading nanomedicines: Progress, current status, and '
'prospects',
'volume': '12',
'author': 'Shen',
'year': '2017',
'journal-title': 'Int. J. Nanomed.'},
{ 'key': 'ref_51',
'doi-asserted-by': 'crossref',
'first-page': '60',
'DOI': '10.1016/j.jconrel.2008.02.014',
'article-title': 'Molecular interactions, internal structure and drug release kinetics of '
'rationally developed polymer–lipid hybrid nanoparticles',
'volume': '128',
'author': 'Li',
'year': '2008',
'journal-title': 'J. Control. Release'},
{ 'key': 'ref_52',
'doi-asserted-by': 'crossref',
'first-page': '259',
'DOI': '10.1007/s10544-011-9604-9',
'article-title': 'Effect of size on the cellular endocytosis and controlled release of '
'mesoporous silica nanoparticles for intracellular delivery',
'volume': '14',
'author': 'Gan',
'year': '2012',
'journal-title': 'Biomed. Microdevices'},
{ 'key': 'ref_53',
'doi-asserted-by': 'crossref',
'first-page': '425',
'DOI': '10.4274/tjps.galenos.2018.82160',
'article-title': 'Effect of surfactant on azithromycin dihydrate loaded stearic acid '
'solid lipid nanoparticles',
'volume': '16',
'author': 'Bhattacharyya',
'year': '2019',
'journal-title': 'Turk. J. Pharm. Sci.'},
{ 'key': 'ref_54',
'doi-asserted-by': 'crossref',
'first-page': '16',
'DOI': '10.1016/j.jddst.2017.02.012',
'article-title': 'Design of lipid-polymer hybrid nanoparticles for therapy of BPH: Part '
'I. Formulation optimization using a design of experiment approach',
'volume': '39',
'author': 'Hascicek',
'year': '2017',
'journal-title': 'J. Drug Deliv. Sci. Technol.'},
{ 'key': 'ref_55',
'doi-asserted-by': 'crossref',
'first-page': 'e03451',
'DOI': '10.1016/j.heliyon.2020.e03451',
'article-title': 'A comparison of models for the analysis of the kinetics of drug release '
'from PLGA-based nanoparticles',
'volume': '6',
'author': 'Jahromi',
'year': '2020',
'journal-title': 'Heliyon'},
{ 'key': 'ref_56',
'doi-asserted-by': 'crossref',
'unstructured': 'Soomherun, N., Kreua-Ongarjnukool, N., Niyomthai, S.T., and Chumnanvej, '
'S. (2024). Lipid-Polymer Hybrid Nanoparticles Synthesized via '
'Lipid-Based Surface Engineering for a robust drug delivery platform. '
'Colloids Surf. B Biointerfaces, 237.',
'DOI': '10.1016/j.colsurfb.2024.113858'},
{ 'key': 'ref_57',
'doi-asserted-by': 'crossref',
'first-page': '298',
'DOI': '10.1177/08839115231167587',
'article-title': 'Fabrication of poloxamer based besifloxacin thermosensitive in situ '
'gelling nanoemulsions for ophthalmic delivery',
'volume': '38',
'author': 'Kassaee',
'year': '2023',
'journal-title': 'J. Bioact. Compat. Polym.'},
{ 'key': 'ref_58',
'doi-asserted-by': 'crossref',
'first-page': '124086',
'DOI': '10.1016/j.ijpharm.2024.124086',
'article-title': 'Codelivery of ivermectin and methyl dihydrojasmonate in nanostructured '
'lipid carrier for synergistic antileukemia therapy',
'volume': '656',
'author': 'Essawy',
'year': '2024',
'journal-title': 'Int. J. Pharm.'},
{ 'key': 'ref_59',
'doi-asserted-by': 'crossref',
'first-page': '856',
'DOI': '10.1080/10837450.2023.2265472',
'article-title': 'Docetaxel liposomes for lung targeted delivery: Development and '
'evaluation',
'volume': '28',
'author': 'Liu',
'year': '2023',
'journal-title': 'Pharm. Dev. Technol.'},
{ 'key': 'ref_60',
'doi-asserted-by': 'crossref',
'unstructured': 'Velho, M.C., Funk, N.L., Deon, M., Benvenutti, E.V., Buchner, S., '
'Hinrichs, R., Pilger, D.A., and Beck, R.C.R. (2024). Ivermectin-Loaded '
'Mesoporous Silica and Polymeric Nanocapsules: Impact on Drug Loading, In '
'Vitro Solubility Enhancement, and Release Performance. Pharmaceutics, '
'16.',
'DOI': '10.3390/pharmaceutics16030325'},
{ 'key': 'ref_61',
'doi-asserted-by': 'crossref',
'first-page': 'e2672',
'DOI': '10.1002/apj.2672',
'article-title': 'Single step encapsulation process of ivermectin in biocompatible '
'polymer using a supercritical antisolvent system process',
'volume': '16',
'author': 'Cardoso',
'year': '2021',
'journal-title': 'Asia-Pac. J. Chem. Eng.'},
{ 'key': 'ref_62',
'doi-asserted-by': 'crossref',
'first-page': '622',
'DOI': '10.1080/10717544.2017.1284945',
'article-title': 'Sustained release ivermectin-loaded solid lipid dispersion for '
'subcutaneous delivery: In vitro and in vivo evaluation',
'volume': '24',
'author': 'Lu',
'year': '2017',
'journal-title': 'Drug Deliv.'},
{ 'key': 'ref_63',
'doi-asserted-by': 'crossref',
'first-page': '2933',
'DOI': '10.1007/s00436-013-3466-4',
'article-title': 'Improved antifilarial activity of ivermectin in chitosan–alginate '
'nanoparticles against human lymphatic filarial parasite, Brugia malayi',
'volume': '112',
'author': 'Ali',
'year': '2013',
'journal-title': 'Parasitol. Res.'},
{ 'key': 'ref_64',
'first-page': '1272',
'article-title': 'Synthesis and evaluation of the effects of solid lipid nanoparticles of '
'ivermectin and ivermectin on cuprizone-induced demyelination via '
'targeting the TRPA1/NF-kB/GFAP signaling pathway',
'volume': '26',
'author': 'Noori',
'year': '2023',
'journal-title': 'Iran. J. Basic Med. Sci.'},
{ 'key': 'ref_65',
'doi-asserted-by': 'crossref',
'first-page': '10685',
'DOI': '10.1021/acs.langmuir.6b03178',
'article-title': 'Encapsulation and controlled release of rapamycin from polycaprolactone '
'nanoparticles prepared by membrane micromixing combined with '
'antisolvent precipitation',
'volume': '32',
'author': 'Othman',
'year': '2016',
'journal-title': 'Langmuir'},
{ 'key': 'ref_66',
'doi-asserted-by': 'crossref',
'first-page': '73',
'DOI': '10.14311/AP.2020.60.0073',
'article-title': 'Analysis of static angle of repose with respect to powder material '
'properties',
'volume': '60',
'author': 'Macho',
'year': '2020',
'journal-title': 'Acta Polytech.'},
{ 'key': 'ref_67',
'doi-asserted-by': 'crossref',
'first-page': '1560',
'DOI': '10.1007/s11051-013-1560-2',
'article-title': 'Spherical agglomerates of pure drug nanoparticles for improved '
'pulmonary delivery in dry powder inhalers',
'volume': '15',
'author': 'Hu',
'year': '2013',
'journal-title': 'J. Nanopart. Res.'},
{ 'key': 'ref_68',
'doi-asserted-by': 'crossref',
'first-page': '171',
'DOI': '10.3109/03639045.2011.592532',
'article-title': 'Development of an inhalation chamber and a dry powder inhaler device '
'for administration of pulmonary medication in animal model',
'volume': '38',
'author': 'Sinha',
'year': '2012',
'journal-title': 'Drug Dev. Ind. Pharm.'},
{ 'key': 'ref_69',
'doi-asserted-by': 'crossref',
'unstructured': 'Marante, T., Viegas, C., Duarte, I., Macedo, A.S., and Fonte, P. (2020). '
'An overview on spray-drying of protein-loaded polymeric nanoparticles '
'for dry powder inhalation. Pharmaceutics, 12.',
'DOI': '10.3390/pharmaceutics12111032'},
{ 'key': 'ref_70',
'doi-asserted-by': 'crossref',
'first-page': '175',
'DOI': '10.1016/j.ejpb.2020.07.011',
'article-title': 'Assessment of nicotine release from nicotine-loaded chitosan '
'nanoparticles dry powder inhaler formulations via locomotor activity of '
'C57BL/6 mice',
'volume': '154',
'author': 'Wang',
'year': '2020',
'journal-title': 'Eur. J. Pharm. Biopharm.'}],
'container-title': 'Pharmaceutics',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://www.mdpi.com/1999-4923/16/8/1061/pdf',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2024, 8, 13]],
'date-time': '2024-08-13T10:19:08Z',
'timestamp': 1723544348000},
'score': 1,
'resource': {'primary': {'URL': 'https://www.mdpi.com/1999-4923/16/8/1061'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2024, 8, 12]]},
'references-count': 70,
'journal-issue': {'issue': '8', 'published-online': {'date-parts': [[2024, 8]]}},
'alternative-id': ['pharmaceutics16081061'],
'URL': 'http://dx.doi.org/10.3390/pharmaceutics16081061',
'relation': {},
'ISSN': ['1999-4923'],
'subject': [],
'container-title-short': 'Pharmaceutics',
'published': {'date-parts': [[2024, 8, 12]]}}
